Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 62

1.

Altered Mental Status at High Altitude.

Ryan S, Dudley N, Green M, Pruitt C, Jackman G.

Pediatrics. 2018 Aug;142(2). pii: e20173973. doi: 10.1542/peds.2017-3973. Epub 2018 Jul 5.

2.

A systematic review of the worldwide prevalence of survivors of poliomyelitis reported in 31 studies.

Jones KM, Balalla S, Theadom A, Jackman G, Feigin VL.

BMJ Open. 2017 Jul 9;7(7):e015470. doi: 10.1136/bmjopen-2016-015470. Review.

3.

Unintentional fatal phosphine gas poisoning of a family.

Lemoine TJ, Schoolman K, Jackman G, Vernon DD.

Pediatr Emerg Care. 2011 Sep;27(9):869-71. doi: 10.1097/PEC.0b013e3182348e40.

PMID:
21926889
4.

Get thee to church: hard work, godliness and tourism at Australia's first rural reformatory.

Jackman G.

Australas Hist Archaeol. 2001;19:6-13. No abstract available.

PMID:
18652042
5.

Role of Tyr(356(7.43)) and Ser(190(4.57)) in antagonist binding in the rat beta1-adrenergic receptor.

Rezmann-Vitti LA, Nero TL, Jackman GP, Machida CA, Duke BJ, Louis WJ, Louis SN.

J Med Chem. 2006 Jun 15;49(12):3467-77.

PMID:
16759089
6.

Agonist binding and activation of the rat beta(1)-adrenergic receptor: role of Trp(134(3.28)), Ser(190(4.57)) and Tyr(356(7.43)).

Rezmann-Vitti LA, Louis SN, Nero TL, Jackman GP, Iakovidis D, Machida CA, Louis WJ.

Biochem Pharmacol. 2004 Aug 15;68(4):675-88.

PMID:
15276075
7.

Site-directed mutagenesis of the rat beta1-adrenoceptor. Involvement of Tyr356 (7.43) in (+/-)cyanopindolol but not (+/-)[125Iodo]cyanopindolol binding.

Rezmann-Vitti LA, Louis SN, Nero TL, Jackman GP, Machida CA, Louis WJ.

Eur J Med Chem. 2004 Jul;39(7):625-31.

PMID:
15236843
8.

Synthesis, beta-adrenoceptor pharmacology and toxicology of S-(-)-1-(4-(2-ethoxyethoxy)phenoxy)-2-hydroxy-3-(2-(3,4-dimethoxyphenyl)ethylamino)propane hydrochloride, a short acting beta(1)-specific antagonist.

Jackman GP, Iakovidis D, Nero TL, Anavekar NS, Rezmann-Vitti LA, Louis SN, Mori M, Drummer OH, Louis WJ.

Eur J Med Chem. 2002 Sep;37(9):731-41.

PMID:
12350290
9.

CoMFA analysis of the human beta(1)-adrenoceptor binding affinity of a series of phenoxypropanolamines.

Louis SN, Rezmann-Vitti LA, Nero TL, Iakovidis D, Jackman GP, Louis WJ.

Eur J Med Chem. 2002 Feb;37(2):111-25.

PMID:
11858844
10.

Seeing is believing: what do boys do when they find a real gun?

Jackman GA, Farah MM, Kellermann AL, Simon HK.

Pediatrics. 2001 Jun;107(6):1247-50.

PMID:
11389238
11.

Role of beta-adrenergic receptor subtypes in lipolysis.

Louis SN, Jackman GP, Nero TL, Iakovidis D, Louis WJ.

Cardiovasc Drugs Ther. 2000 Dec;14(6):565-77.

PMID:
11300357
12.

beta(1)- and beta(2)-Adrenoceptor antagonist activity of a series of para-substituted N-isopropylphenoxypropanolamines.

Louis SN, Nero TL, Iakovidis D, Colagrande FM, Jackman GP, Louis WJ.

Eur J Med Chem. 1999 Nov 1;34(11):919-937.

PMID:
10889317
13.

Radiological case of the month. Military tuberculosis with meningitis.

Jackman GA.

Arch Pediatr Adolesc Med. 1999 Aug;153(8):887-8. No abstract available.

PMID:
10437766
14.

LK 204-545, a highly selective beta1-adrenoceptor antagonist at human beta-adrenoceptors.

Louis SN, Nero TL, Iakovidis D, Jackman GP, Louis WJ.

Eur J Pharmacol. 1999 Feb 19;367(2-3):431-5.

PMID:
10079020
15.

Pharmacology and subcellular distribution of [3H]rilmenidine binding sites in rat brain.

Hosseini AR, Jackman GP, King PR, Louis WJ, Gundlach AL.

J Auton Nerv Syst. 1998 Oct 15;72(2-3):129-36.

PMID:
9851561
16.
17.

Non-invasive assessment of baroreflex sensitivity and relation to measures of heart rate variability in man.

Pellizzer AM, Kamen PW, Jackman G, Brazzale D, Krum H.

Clin Exp Pharmacol Physiol. 1996 Jun-Jul;23(6-7):621-4.

PMID:
8800605
18.

The effect of levcromakalim (BRL 38227) on bladder function in patients with high spinal cord lesions.

Komersova K, Rogerson JW, Conway EL, Lim TC, Brown DJ, Krum H, Jackman GP, Murdoch R, Louis WJ.

Br J Clin Pharmacol. 1995 Feb;39(2):207-9.

19.

A simple and reliable method for construction of parallel multibarrel microelectrodes.

Verberne AJ, Owens NC, Jackman GP.

Brain Res Bull. 1995;36(1):107-8.

PMID:
7882042
20.

Rapidly developing pseudohypertension after renal transplantation diagnosed by non-auscultated blood pressure measurement.

O'Callaghan CJ, Louis WJ, Hart GK, Jackman G, Howes LG, Miach P.

Nephron. 1994;67(1):101-3.

PMID:
8052349
21.

Partial agonist activity of celiprolol.

Tung LH, Jackman G, Campbell B, Louis S, Iakovidis D, Louis WJ.

J Cardiovasc Pharmacol. 1993 Mar;21(3):484-8.

PMID:
7681512
22.

Computer-aided mapping of the beta-adrenoceptor. 1. Explanation for effect of para substitution on blocking activity at the beta-1-adrenoceptor.

Ball JB, Nero TL, Iakovidis D, Tung L, Jackman G, Louis WJ.

J Med Chem. 1992 Dec 11;35(25):4676-82.

PMID:
1361581
23.

Validation of a solid-phase extraction high-performance liquid chromatographic assay for doxazosin.

Jackman GP, Colagrande F, Louis WJ.

J Chromatogr. 1991 May 3;566(1):234-8.

PMID:
1679435
24.

Diurnal blood pressure variation in quadriplegic chronic spinal cord injury patients.

Krum H, Louis WJ, Brown DJ, Jackman GP, Howes LG.

Clin Sci (Lond). 1991 Mar;80(3):271-6.

PMID:
1850688
25.

Simplified procedure to remove radiolabeled contaminants after [3H]norepinephrine infusions.

Jackman GP, Rowe P, Howes LG.

Clin Chem. 1990 Aug;36(8 Pt 1):1520-1. No abstract available.

PMID:
2387053
26.

Angiotensin II and noradrenaline increase PDGF-BB receptors and potentiate PDGF-BB stimulated DNA synthesis in vascular smooth muscle.

Bobik A, Grinpukel S, Little PJ, Grooms A, Jackman G.

Biochem Biophys Res Commun. 1990 Jan 30;166(2):580-8.

PMID:
2154213
27.
28.
29.

Analysis of milrinone in plasma using solid-phase extraction and high-performance liquid chromatography.

Oddie CJ, Jackman GP, Bobik A.

J Chromatogr. 1986 Jan 10;374(1):209-14. No abstract available.

PMID:
3949932
30.

Evidence for a predominantly central hypotensive effect of alpha-methyldopa in humans.

Bobik A, Jennings G, Jackman G, Oddie C, Korner P.

Hypertension. 1986 Jan;8(1):16-23.

PMID:
3943883
31.

High-performance liquid chromatographic determination of plasma catecholamines during alpha-methyldopa therapy.

Jackman GP, Oddie CJ, Skews H, Bobik A.

J Chromatogr. 1984 Jun 8;308:301-5. No abstract available.

PMID:
6378949
32.

Measurement of xamoterol in plasma and urine by high-performance liquid chromatography.

Oddie CJ, Jackman GP, Bobik A.

J Chromatogr. 1984 Jun 8;308:370-5. No abstract available.

PMID:
6146637
34.

Role of autoinhibitory feedback in cardiac sympathetic transmission.

Angus JA, Korner PI, Jackman GP, Bobik A, Kopin IJ.

Clin Exp Hypertens A. 1984;6(1-2):371-85.

PMID:
6321065
35.

Analysis of bopindolol and its active metabolite 18-502 in human plasma by high-performance liquid chromatography.

Oddie CJ, Jackman GP, Bobik A.

J Chromatogr. 1983 Apr 8;273(2):469-74. No abstract available.

PMID:
6863461
36.

Determination of prenalterol in plasma by high-performance liquid chromatography with fluorescence detection.

Oddie CJ, Jackman GP, Bobik A.

J Chromatogr. 1982 Sep 10;231(2):473-7. No abstract available.

PMID:
7130326
39.

The peripheral kinetics of norepinephrine in depressive illness.

Esler M, Turbott J, Schwarz R, Leonard P, Bobik A, Skews H, Jackman G.

Arch Gen Psychiatry. 1982 Mar;39(3):295-300.

PMID:
7065840
40.

Biochemical quantification of sympathetic nervous activity in humans using radiotracer methodology: fallibility of plasma noradrenaline measurements.

Esler M, Leonard P, O'Dea K, Jackman G, Jennings G, Korner P.

J Cardiovasc Pharmacol. 1982;4 Suppl 1:S152-7.

PMID:
6175831
41.

Differing noradrenaline kinetics in essential hypertension and depressive illness, two diseases in which the plasma concentration of noradrenaline is sometimes elevated.

Esler M, Turbott J, Schwarz R, Leonard P, Jackman G, Skews H, Bobik A, Jennings G, Korner P.

Clin Exp Pharmacol Physiol. 1981 Sep-Oct;8(5):525-30.

PMID:
7326875
42.

Effect of propranolol on noradrenaline kinetics in patients with essential hypertension.

Esler M, Jackman G, Leonard P, Skews H, Bobik A, Jennings G.

Br J Clin Pharmacol. 1981 Sep;12(3):375-80.

43.

No stereoselective first-pass hepatic extraction of propranolol.

Jackman GP, McLean AJ, Jennings GL, Bobik A.

Clin Pharmacol Ther. 1981 Sep;30(3):291-6.

PMID:
7273593
45.

Norepinephrine kinetics in essential hypertension. Defective neuronal uptake of norepinephrine in some patients.

Esler M, Jackman G, Bobik A, Leonard P, Kelleher D, Skews H, Jennings G, Korner P.

Hypertension. 1981 Mar-Apr;3(2):149-56.

PMID:
7216371
46.

Age-dependence of noradrenaline kinetics in normal subjects.

Esler M, Skews H, Leonard P, Jackman G, Bobik A, Korner P.

Clin Sci (Lond). 1981 Feb;60(2):217-9.

PMID:
7237935
47.

Effect of norepinephrine uptake blockers on norepinephrine kinetics.

Esler M, Jackman G, Leonard P, Skews H, Bobik A, Korner P.

Clin Pharmacol Ther. 1981 Jan;29(1):12-20.

PMID:
7460470
48.

Determination of noradrenaline uptake, spillover to plasma and plasma concentration in patients with essential hypertension.

Esler M, Jackman G, Leonard P, Bobik A, Skews H, Jennings G, Kelleher D, Korner P.

Clin Sci (Lond). 1980 Dec;59 Suppl 6:311s-313s.

PMID:
7449275
49.

Improved liquid-chromatographic assay of urinary catecholamines.

Jackman GP.

Clin Chem. 1980 Oct;26(11):1623-4. No abstract available.

50.

Assessment of neuronal uptake of noradrenaline in humans: defective uptake in some patients with essential hypertension.

Esler M, Leonard P, Kelleher D, Jackman G, Bobik A, Skews H, Jennings G, Korner P.

Clin Exp Pharmacol Physiol. 1980 Sep-Oct;7(5):535-9.

PMID:
7449197

Supplemental Content

Loading ...
Support Center